Introduction Due to the increased prevalence of osteoarthritis (OA) and osteoporosis (OP) in women, urgent interventions are needed to reduce the risk of postmenopausal fractures in female OA patients. Moreover, the relationship between OA and OP remains contentious, emphasizing the need for further research to deepen our understanding. This study aimed to investigate the relationship between OA and postmenopausal OP using data from the National Health and Nutrition Examination Survey (NHANES). Methods We conducted a cross-sectional analysis using NHANES summary data from 2005 to 2010, 2013 to 2014, and 2017 to 2020. Multivariable logistic regression was employed to evaluate the association between OA and the risk of postmenopausal OP. Adjustments were made for potential confounding factors. Additionally, we conducted stratified analyses, which provided further insights into the association between OA and postmenopausal OP across various subgroups. Results The analysis revealed a significant correlation between OA and an increased risk of postmenopausal OP, with an odds ratio (OR) of 1.12 (95% confidence interval (CI): 1.07-1.17, P < 0.001) after adjusting for confounders. Stratified analyses revealed a significant association between OA and postmenopausal OP in obese and overweight individuals (OR 1.14, 95% CI 1.06-1.22, P < 0.001; OR 1.18, 95% CI 1.04-1.32, P = 0.008) and among former or current smokers (OR 1.20, 95% CI 1.08-1.33, P < 0.001). Conclusions The study underscores a significant association between OA and postmenopausal OP, particularly in obese, overweight, and smoking populations. Given the higher prevalence of OA and OP among women, understanding these associations could lead to improved strategies for reducing postmenopausal fracture risks. The study offers valuable insights and potential directions for future therapeutic approaches.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571265 | PMC |
http://dx.doi.org/10.7759/cureus.71734 | DOI Listing |
Phytomedicine
January 2025
Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. Electronic address:
People with mild cognitive impairment (MCI) carry a considerable risk of developing dementia. Studies have shown that female sex hormones have long-lasting neuroprotective and anti-aging properties, and the increased risk of MCI and AD is associated with the lack of estrogen during menopause. Previous studies have shown that Tiao Geng Decoction (TGD) may have antioxidant and anti apoptotic properties, which may prevent neurodegenerative diseases.
View Article and Find Full Text PDFJNCI Cancer Spectr
January 2025
Department of Epidemiology and Biostatistics, University of California, Irvine, CA, USA.
Background: Obesity, classified by body mass index (BMI), is associated with higher postmenopausal breast cancer (BCa) risk. Yet, the associations between abdominal visceral (VAT) and subcutaneous adipose tissue (SAT) with BCa are unclear.
Methods: We assessed BCa associations with abdominal VAT and SAT in a prospective cohort of postmenopausal women without a history of cancer and with 27 years follow-up (N = 9950), during which all new cancers were adjudicated.
Sci Rep
January 2025
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, P.R. China.
The essential cause of menopause is ovarian failure, which can cause decline in sex hormones (especially estrogen) that can increase the risk of metabolic diseases, such as cardiovascular disease and osteoporosis. This study screened 1511 eligible patients from 2148 perimenopausal and postmenopausal women, measuring various physiological and biochemical indicators to analyze differences among age groups (40-44, 45-49, and 50-54 years) with laboratory techniques. The study found no significant difference in the incidence of cardiovascular disease betweenperimenopausal and postmenopausal women.
View Article and Find Full Text PDFPLoS One
January 2025
University of Michigan Medical School, Ann Arbor, MI, United States of America.
Background: Aromatase inhibitors (AI) reduce hormone receptor-positive breast cancer recurrence risk by about 50%. However, half of AI-treated postmenopausal women report new or worsened musculoskeletal symptoms (AIMSS), and 20% discontinue therapy prematurely. Acupuncture is effective for reducing symptoms, but many women are not able to access acupuncture therapy.
View Article and Find Full Text PDFCancer Res
January 2025
Vanderbilt University, Nashville, TN, United States.
Obesity is an established risk factor for breast cancer development and poor prognosis. The adipose environment surrounding breast tumors, which is inflamed in obesity, has been implicated in tumor progression, and TREM2, a transmembrane receptor expressed on macrophages in adipose tissue and tumors, is an emerging therapeutic target for cancer. A better understanding of the mechanisms for the obesity-breast cancer association and the potential benefits of weight loss could help inform treatment strategies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!